Early-onset infant epileptic encephalopathy associated with a de novo PPP3CA gene mutation

Area of Science:

• Neurogenetics
• Molecular Biology
• Developmental Neuroscience

Background:

• Epileptic encephalopathies are severe neurological disorders characterized by intractable seizures and intellectual disability.
• Genetic factors, particularly rare de novo mutations, play a significant role in early-onset epilepsy and neurodevelopmental diseases.
• Whole-exome sequencing is a powerful tool for identifying causative genetic variants in complex disorders.

Observation:

• A novel de novo frameshift mutation (c.1255_1256del, p.Ser419Cysfs*31) was identified in the PPP3CA gene.
• The mutation was found in an 11.5-month-old female infant presenting with early-onset refractory epilepsy and global developmental delay.
• The PPP3CA gene encodes the catalytic subunit A of calcineurin, a crucial calcium-dependent protein phosphatase.

Findings:

• The identified mutation represents a new genetic cause linked to severe early-onset neurodevelopmental disease with seizures.
• This finding expands the spectrum of known PPP3CA mutations associated with pediatric neurological conditions.
• Detailed clinical characterization of the affected individual provides further insights into the phenotype associated with this mutation.

Implications:

• This discovery contributes to a deeper understanding of the genetic architecture of epileptic encephalopathies.
• Identifying specific gene mutations like the one in PPP3CA can inform diagnostic approaches and genetic counseling for affected families.
• Further research into the functional consequences of PPP3CA mutations may reveal potential therapeutic targets for related neurodevelopmental disorders.